Approvals/TGA/IPRAVENT ipratropium bromide monohydrate 21 microgram HFA pressurised metered dose inhaler

Approved

STANDARD

IPRAVENT ipratropium bromide monohydrate 21 microgram HFA pressurised metered dose inhaler

Cipla Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: dbc62b60533210af
Product Name: IPRAVENT ipratropium bromide monohydrate 21 microgram HFA pressurised metered dose inhaler
Artg Id: 410013
Artg Name: IPRAVENT ipratropium bromide monohydrate 21 microgram HFA pressurised metered dose inhaler
Sponsor: Cipla Australia Pty Ltd
Company Detail Path: /organization/cipla-australia-pty-ltd
Artg Date: 2025-05-27
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

dbc62b60533210af

Type

Standard